S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
Log in

NASDAQ:VIST - Visterra Stock Price, Forecast & News

$7.44
-0.16 (-2.11 %)
(As of 02/18/2020 04:00 PM ET)
Add
Today's Range
$7.20
Now: $7.44
$7.56
50-Day Range
$6.71
MA: $7.55
$8.22
52-Week Range
$3.80
Now: $7.44
$11.03
Volume47,200 shs
Average Volume97,550 shs
Market Capitalization$646.05 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Visterra Inc is a United States-based biotechnology company. The Company uses its Atomic Interaction Network analysis to identify disease targets and design effective therapeutics. The Company's technology is based on its Hierotope Platform, which identifies an area, or epitope, on the target protein, glycoprotein or glycan that is fundamental to its structure and function. The Company's Hierotope Platform is able to identify the region of the protein, or epitope, which is structurally constrained, and thus prevented from mutation over time or under immunological or therapeutic pressure. Its technology for creating potent and therapeutics is powered by the Company's computational tools and techniques, the core of which is called Atomic Interaction Network (AIN) analysis.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:VIST
CUSIPN/A
Phone+1-617-4981070

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$646.05 million
Next Earnings Date2/20/2020 (Estimated)
OptionableNot Optionable

Receive VIST News and Ratings via Email

Sign-up to receive the latest news and ratings for VIST and its competitors with MarketBeat's FREE daily newsletter.


Visterra (NASDAQ:VIST) Frequently Asked Questions

What is Visterra's stock symbol?

Visterra trades on the NASDAQ under the ticker symbol "VIST."

When is Visterra's next earnings date?

Visterra is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Visterra.

Has Visterra been receiving favorable news coverage?

News coverage about VIST stock has been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Visterra earned a news sentiment score of -1.8 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Visterra.

What other stocks do shareholders of Visterra own?

When did Visterra IPO?

(VIST) raised $95 million in an IPO on Friday, July 26th 2019. The company issued 10,000,000 shares at $9.46 per share. Citigroup and Credit Suisse acted as the underwriters for the IPO and Itau BBA, Morgan Stanley and Santander were co-managers.

When did the company's lock-up period expire?

Visterra's lock-up period expired on Wednesday, January 22nd. Visterra had issued 10,000,000 shares in its IPO on July 26th. The total size of the offering was $92,500,000 based on an initial share price of $9.25. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

Who are Visterra's major shareholders?

Visterra's stock is owned by many different of retail and institutional investors. Top institutional investors include Oaktree Capital Management LP (2.91%), Amundi Pioneer Asset Management Inc. (0.87%), New York State Common Retirement Fund (0.18%), Victory Capital Management Inc. (0.06%), Victory Capital Management Inc. (0.06%) and Oxford Asset Management LLP (0.04%).

Which institutional investors are buying Visterra stock?

VIST stock was bought by a variety of institutional investors in the last quarter, including Oaktree Capital Management LP, Victory Capital Management Inc., Victory Capital Management Inc., New York State Common Retirement Fund, Oxford Asset Management LLP, Amundi Pioneer Asset Management Inc. and Acadian Asset Management LLC.

How do I buy shares of Visterra?

Shares of VIST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Visterra's stock price today?

One share of VIST stock can currently be purchased for approximately $7.44.

How big of a company is Visterra?

Visterra has a market capitalization of $646.05 million. View Additional Information About Visterra.

What is Visterra's official website?

The official website for Visterra is http://www.visterrainc.com/.

How can I contact Visterra?

Visterra's mailing address is 1 Kendall Sq Ste B3301, CAMBRIDGE, MA 02139-1604, United States. The biotechnology company can be reached via phone at +1-617-4981070.


MarketBeat Community Rating for Visterra (NASDAQ VIST)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  120
MarketBeat's community ratings are surveys of what our community members think about Visterra and other stocks. Vote "Outperform" if you believe VIST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VIST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Inverted Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel